BioSpace News Archive

rBIO, an early-stage synthetic biology company focused on reducing the cost of increasingly costly biologic therapies, announced refinement of its bacteria-based production of insulin.

Omega Therapeutics will present preclinical data on its novel Omega Epigenomic Controller (OEC) to regulate expression of the c-Myc (MYC) oncogene via epigenomic programming in models of NSCLC in a poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting, taking place in Washington, D.C., May 16-19, 2022.

Blueprint Medicines Corporation (NASDAQ: BPMC) today reported financial results and provided a business update for the first quarter ended March 31, 2022.

Lutris Pharma today announced that Benjamin W. Corn , MD, PhD, Chief Medical Officer, will present a company overview at the Bio€quity Europe 2022 conference taking place in Milan, Italy May 17-18, 2022.

Epizyme today announced that management will host a conference call to discuss its first quarter 2022 financial results and provide a business update on Tuesday, May 10, 2022 at 8:30 a.m. ET.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the quarter ended March 31, 2022.

Agile Therapeutics, Inc. today announced it will report first quarter 2022 financial results after the market close on Thursday, May 12, 2022.

LEXEO Therapeutics today announced that new preclinical data supporting its plakophilin-2 (PKP2) will be presented at the 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), which is being held live in Washington, D.C. and virtually from May 16-19, 2022.

Quipt Home Medical Corp. today announced that it will host its Fiscal Q2 2022 earnings conference call and audio webcast on Tuesday, May 17, 2022 at 10:00 a.m. (EST).

Aptose Biosciences Inc. today announced that Dr. William G. Rice, Chairman, President and CEO of Aptose, will participate in the RBC Capital Markets Global Healthcare Conference.